Varex Imaging (NASDAQ:VREX) Upgraded at Zacks Research

Zacks Research upgraded shares of Varex Imaging (NASDAQ:VREX) from a hold rating to a strong-buy rating in a research note published on Monday,Zacks.com reports.

A number of other equities analysts also recently commented on VREX. B. Riley Financial reaffirmed a “buy” rating on shares of Varex Imaging in a research note on Thursday, February 12th. Wall Street Zen raised shares of Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a report on Friday, March 27th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a research report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Varex Imaging currently has a consensus rating of “Moderate Buy” and an average price target of $16.17.

Varex Imaging Stock Up 0.3%

Shares of NASDAQ:VREX opened at $11.78 on Monday. Varex Imaging has a 52-week low of $6.76 and a 52-week high of $14.56. The stock has a market cap of $493.58 million, a P/E ratio of -7.18 and a beta of 0.99. The business has a fifty day moving average of $12.03 and a two-hundred day moving average of $12.14. The company has a quick ratio of 1.87, a current ratio of 3.89 and a debt-to-equity ratio of 0.75.

Varex Imaging (NASDAQ:VREX) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.14 by $0.05. Varex Imaging had a positive return on equity of 8.43% and a negative net margin of 7.92%.The business had revenue of $209.60 million for the quarter, compared to analyst estimates of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, research analysts expect that Varex Imaging will post 0.53 earnings per share for the current year.

Insider Buying and Selling at Varex Imaging

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $11.14, for a total transaction of $50,241.40. Following the completion of the sale, the director directly owned 23,450 shares in the company, valued at $261,233. This trade represents a 16.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Varex Imaging

Hedge funds have recently made changes to their positions in the stock. State of Alaska Department of Revenue purchased a new stake in Varex Imaging in the third quarter valued at approximately $27,000. Rockefeller Capital Management L.P. purchased a new position in shares of Varex Imaging during the fourth quarter worth $27,000. Quarry LP acquired a new stake in shares of Varex Imaging in the third quarter valued at $64,000. Aquatic Capital Management LLC acquired a new stake in shares of Varex Imaging in the third quarter valued at $117,000. Finally, Legato Capital Management LLC purchased a new stake in shares of Varex Imaging in the 3rd quarter valued at $125,000.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.